...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces One-Year Extension of Debenture

"Nellie, that means you've concluded the Covid trial will be a failure.  We'll know soon enough......."

 

Yepper,,,we will know,,,hummm,,,I doubt it very much that the trial design is focused on the MOA of apabetalone,,,,,maybe a 3rd party knows more,,we dont,,very possibly so,,,it is clear our team are cavemen looking at a coke can here,,or havent you noticed!,,,,I have resigned myself to the inevitable,,where our history should tell us this much,,,,we will need a Plll trial to prove out a small portion of the trial that sort of succeeded,,,,the share price will respond accordingly where the invested money will be seen as a dead investment for at least another year,,,watch and see,,,,,no stopppping of this trial due to exciting realtime results,,,there is not a smidgen of a chance this C19 trial meets end points....it might come close,,but nope no cigar for shareholders on this one either me thinks!!!,,the Market is not being fooled....7 year lows coming,,,,..jmo

Share
New Message
Please login to post a reply